<DOC>
	<DOCNO>NCT01083329</DOCNO>
	<brief_summary>Our work hypothesis postulate lipolysis determinant inflammation adipose tissue ( AT ) . Inhibition lipolysis , e.g . use old normolipidemic drug , nicotinic acid , prove valuable combat metabolic syndrome . Our proposal determine whether part beneficial effect antilipolytic compound due diminution AT inflammation . To aim , effect nicotinic acid placebo study male obese subject without train program goal enhance lipolysis .</brief_summary>
	<brief_title>Effect Nicotinic Acid Adipose Tissue Inflammation Obese Subjects</brief_title>
	<detailed_description>24 male obese insulin resistant subject receive nicotinic acid placebo 16 week . The last 8 week , subject follow train program calculate optimize use lipid . Insulin sensitivity glucose tolerance assess use , respectively , fasting-based estimate insulin sensitivity ( plasma muscle ) oral glucose tolerance test . Plasma parameter adipokines , inflammatory metabolic parameter determine . As index AT inflammation , percentage phenotype macrophage determine use flow cytometry cell stromavascular fraction subcutaneous AT . Macrophage infiltration investigate light microscopy . The characterization inflammatory profile AT complete measurement expression gene either specific marker human AT macrophage inflammatory anti-inflammatory adipokines . This combination approach never carry pharmacological intervention human . The following point address : - determine influence lipolysis AT inflammation , specifically macrophage activation adipokine production . - examine causal relationship adipocyte FA metabolism , AT inflammation insulin sensitivity . - establish whether beneficial effect antilipolytic drug may attributable least part decrease AT inflammation .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Signature inform consent form Age 25 45 yearold Male , insulin resistant obese subject ( 30 &lt; BMI &lt; 40 kg/m2 ) , Blood arterial pressure &lt; 140/90 mmHg History cardiovascular disease Treatment drug interfere cardiovascular system autonomic nervous system ( i.e . beta blocker ) . Treatment nicotinic acid Treatment fibrates , statin , cholestyramine ezetimibe Treatment thiazidics Fasted hyperglycaemia &gt; 1,26 g/l ( Diabetes ) Triglycerides &gt; 5 g/l Blood arterial pressure &gt; 140/90 mm Hg</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>nicotinic acid</keyword>
	<keyword>lipolysis</keyword>
	<keyword>train program</keyword>
	<keyword>adipose tissue inflammation</keyword>
	<keyword>obese</keyword>
</DOC>